Glioblasztóma: vizsgálatok itt: Norvégia
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleStudy to evaluate the therapeutic effect of a cell based immune therapy targeting cancer stem cells i the malignant brain tumor glioblastoma.
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 60
- Run by
- Oslo University Hospital HF
See details and how to joinNCT03548571 · EU 2024-518663-35-00 - 3. fázisTaking peoplePhase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated glioblastoma (IDHwt) patients +/- tumor treating fields (Optune)
- Where
- Bergen, Graalum, Kristiansand S, Oslo, Stavanger, Tromsoe, Trondheim
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Vaestra Goetalandsregionen
See details and how to join2023-506998-35-00 · EU 2023-506998-35-00 - 1/2. fázisTaking peopleBortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
- Where
- Bergen, Oslo, Tromsoe, Trondheim
- Életkor
- 18 év and over
- People
- 63
- Run by
- Haukeland University Hospital
See details and how to joinNCT03643549 · EU 2024-515142-16-00 - 3. fázisTaking peopleLomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
- Where
- Oslo, Trondheim
- Életkor
- 18 év and over
- People
- 411 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00 - 1. fázisTaking peopleA study to investigate how a single dose of the drug melflufen reaches brain tumor tissue, and how it affects the tumour, in patients who are already scheduled for surgery for a returning glioblastoma
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 10
- Run by
- Oncopeptides AB
See details and how to join2026-525543-32-00 · EU 2026-525543-32-00 - 1/2. fázisNot yet taking people in NorvégiaThe ALPINE trial: a phase 1-2 study of intra-arterial [177Lu]Lu-PSMA-I&T for progressive or recurrent intracranial adult type diffuse glioma
- Where
- Trondheim
- Életkor
- 18 év to 64 év
- People
- 28 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504696-24-00 · EU 2023-504696-24-00 - 3. fázisTaking peopleLomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
- Where
- Bergen, Kristiansand, Oslo, Stavanger, Trondheim
- Életkor
- 18 év to 70 év
- People
- 200 worldwide
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06419946 - 1. fázisTaking peopleIndividualized Systems Medicine strategy to target cancer stem cells in patients with recurrent Glioblastoma (ISM-GBM)
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 15
- Run by
- Oslo University Hospital HF
See details and how to joinNCT05043701 · EU 2023-510214-11-00